Van Eck Associates Corp Bio Techne Corp Transaction History

Van Eck Associates Corp

$77.4 Billion
Q1 2025

A detailed history of Van Eck Associates Corp transactions in Bio Techne Corp stock. As of the latest transaction made, Van Eck Associates Corp holds 225,590 shares of TECH stock, worth $11.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

225,590

Previous 171,557 31.5%

Holding current value

$11.6 Million

Previous $12.4 Million 7.03%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$58.47 - $78.75 $3.16 Million - $4.26 Million	54,033 Added 31.5%	225,590 $13.2 Million
Q4 2024 Jan 29, 2025	BUY	$66.37 - $78.17 $3.29 Million - $3.88 Million	49,574 Added 40.64%	171,557 $12.4 Million
Q3 2024 Oct 29, 2024	SELL	$70.96 - $82.35 $1.44 Million - $1.67 Million	-20,226 Reduced 14.22%	121,983 $8.46 Million
Q2 2024 Jul 31, 2024	BUY	$62.12 - $84.15 $209,530 - $283,837	3,373 Added 2.43%	142,209 $10.2 Million
Q1 2024 Apr 30, 2024	SELL	$65.98 - $77.09 $268,208 - $313,370	-4,065 Reduced 2.84%	138,836 $9.77 Million
Q4 2023 Feb 05, 2024	SELL	$52.83 - $78.22 $1.2 Million - $1.77 Million	-22,664 Reduced 13.69%	142,901 $11 Million
Q3 2023 Nov 08, 2023	BUY	$67.52 - $89.42 $479,121 - $634,524	7,096 Added 4.48%	165,565 $11.3 Million
Q2 2023 Aug 03, 2023	SELL	$73.76 - $85.98 $426,849 - $497,566	-5,787 Reduced 3.52%	158,469 $12.9 Million
Q1 2023 May 03, 2023	SELL	$71.62 - $86.62 $1.76 Million - $2.13 Million	-24,551 Reduced 13.0%	164,256 $12.2 Million
Q4 2022 Feb 08, 2023	BUY	$80.67 - $352.29 $12.2 Million - $53.4 Million	151,488 Added 405.93%	188,807 $15.6 Million
Q3 2022 Oct 27, 2022	SELL	$282.54 - $391.85 $4.44 Million - $6.16 Million	-15,713 Reduced 29.63%	37,319 $10.6 Million
Q2 2022 Aug 03, 2022	BUY	$322.67 - $449.65 $932,838 - $1.3 Million	2,891 Added 5.77%	53,032 $18.4 Million
Q1 2022 May 10, 2022	BUY	$353.85 - $487.79 $869,763 - $1.2 Million	2,458 Added 5.15%	50,141 $21.7 Million
Q4 2021 Jan 26, 2022	SELL	$456.15 - $525.06 $554,678 - $638,472	-1,216 Reduced 2.49%	47,683 $24.7 Million
Q3 2021 Nov 03, 2021	BUY	$444.87 - $538.88 $21.8 Million - $26.4 Million	48,899 New	48,899 $23.7 Million
Q2 2021 Aug 10, 2021	SELL	$387.35 - $450.26 $81,343 - $94,554	-210 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$314.62 - $411.0 $66,070 - $86,310	210 New	210 $80,000

Others Institutions Holding TECH

# of Institutions

627

Shares Held

160M

Call Options Held

90K

Put Options Held

14.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.02B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Bio Techne Corp Transaction History